Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Daedalus Software was a healthcare information technology company that specialized in biospecimen management and biobanking software solutions. The company's flagship product, T-SOP, provided a comprehensive platform for managing the collection, processing, and distribution of human biospecimens for research. By automating complex workflows and ensuring regulatory compliance, Daedalus helped clinical sites and researchers streamline the procurement of high-quality biological samples. The software was designed to bridge the gap between clinical care and research by identifying eligible patients and managing the consent process. In 2014, the company was acquired by iSpecimen to enhance its marketplace for human biospecimens. This acquisition integrated Daedalus's technology into iSpecimen's platform to better connect researchers with specimen providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Daedalus Software.